Following an excellent presentation at the EAACI Digital Congress 2020, we caught up with Jacklyn Ann Smith (University of Manchester, UK) to discuss the mechanisms of chronic cough and the burden the condition can have on patients.
1.What are the major mechanisms involved in chronic cough? (0:07)
2.Could you tell us little about the physical, social and psychological consequences of chronic cough? (0:47)
3.What are the limitations of the current management of chronic cough in primary care settings? (2:21)
4.What tests do you recommend in the diagnosis and monitoring of chronic cough? (3:22)
5.What advice would you give to allergists regarding optimal treatment of chronic cough? (4:28)
Disclosures: Jaclyn Ann Smith has received grants from Merck, Ario Pharma, GlaxoSmithKline, NeRRe Pharmaceuticals, Menlo, Bellus, and Bayer; personal fees from Chiesi, Ario Pharma, GlaxoSmithKline, NeRRe Pharmaceuticals, Menlo, Bellus, Bayer, Boehringer Ingleheim, Genentech, and Neomed.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the EAACI Digital Congress 2020.
Share this Video
Related Videos In Chronic Cough
Alan Kaplan: The IPCRG Sentinel Network and Respiratory Q&A
We were delighted to meet with Prof. Alan Kaplan (University of Toronto, Toronto, ON, Canada) to discuss the international IPCRG Sentinel Network which represents each continent and includes over 100 primary care clinicians. The IPCRG is providing answers based on published peer reviewed evidence to COVID and respiratory questions from the Sentinel Network. Questions Could […]
James Wingfield Digby, ERS 2022: Hypotonic Saline in the Diagnosis of Refractory/Unexplained Chronic Cough
Chronic cough is a persistent cough lasting ≥8 weeks and is estimated to affect between 2-18% of the global population; however chronic cough is often unrecognized, underdiagnosed and there remain many unmet needs in its treatment. It was a pleasure to speak with Dr. James Wingfield Digby (University of Manchester, Manchester, UK) around his study […]
James Wingfield Digby, ERS 2022: Low-dose Opiates for Refractory/Unexplained Chronic Cough
Chronic cough is a persistent cough lasting ≥8 weeks and is estimated to affect between 2-18% of the global population. touchRESPIRATORY were delighted to speak with Dr. James Wingfield Digby (University of Manchester, Manchester, UK) around the aims and design of the real world study investigating low-dose opiates in the treatment of chronic cough and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!